Target ALS grants and core resources dedicated to TDP-43-Targeted Therapeutics Gagan Moorthy · Jun 12, 2025 ·
Driving Urgency and Hope: Dr. Björn Oskarsson on Biofluids, Biomarkers, and the Future of ALS Research Gagan Moorthy · Jun 12, 2025 ·
Rethinking “Junk” DNA: Yini Li’s Bold Bet on RNA, Epigenetics, and ALS Gagan Moorthy · Jun 12, 2025 ·
Charting the Future of ALS Trials with Digital Twins: A Conversation with Dr. Robert McFarlane Gagan Moorthy · Jun 5, 2025 ·
A Personal Mission, A Global Lens: Dr. Senda Ajroud-Driss on the Promise of ALS Research Gagan Moorthy · Jun 5, 2025 ·
Trailblazing a New Frontier in ALS Treatment: Dr. Claire Clelland’s Bold CRISPR Strategy to Rewrite the Future Gagan Moorthy · May 19, 2025 ·
Unlocking ALS Risk in South Asian Populations: Inside a Groundbreaking Genetic Study Led by India and the UK Gagan Moorthy · May 13, 2025 ·
Turning Sight into Insight: How Amydis Is Using the Retina to Rethink ALS Screening and Diagnostics Gagan Moorthy · May 9, 2025 ·
Expanding the Frontiers of ALS Research: South Korea Joins the Target ALS Global Study Gagan Moorthy · May 5, 2025 ·
